Presentation

Dear members of IRYCIS and external visitors who are getting to know us through this website, I would like to welcome you to our accredited Health Research Institute.

The year 2020 was undoubtedly a year that is difficult to describe with a single adjective, but very easy to summarize with a single word that describes the work carried out by the professionals who make up our Institute: ADMIRABLE. Allow me to dedicate this first paragraph to all the healthcare staff that make up IRYCIS, whose excellent scientific profile (IRYCIS was the Madrid institute with the highest number of studies and trials on COVID-19 patients during the first wave) and patient care only surpassed by their extraordinary human quality. To all of them: THANK YOU VERY MUCH.

Now, with enthusiasm, we are in the second decade of our Institute's existence, which was founded in 2009. We have begun a period of expanding IRYCIS's capabilities and talent, as well as identifying unique features and added value, in order to strengthen our position as a center of excellence on the national stage, enhance our international leadership, and achieve significant milestones that benefit patients and society. All of this will only be possible if we continue to demonstrate a high level of professionalism, a strong spirit of collaboration, and a deep sense of belonging (the IRYCIS brand). We should take pride in being members of an Institute that exhibits one of the most important biological traits for life: adaptability. This adaptability to circumstances allows us to face new challenges, overcome increasingly high thresholds of demand, and approach this new stage of maturity and growth as an Institute with higher levels of training, preparation, and unity than ever before.

Currently, IRYCIS encompasses 42 research groups and hosts over 1,200 individuals engaged in research and innovation, including around 400 Clinical Research Associates.

With the effective management and constant support of our governing body, FIBioHRC, which is absolutely indispensable, IRYCIS achieves new activity records each year and, even more importantly, is reinforcing itself to increase these achievements year after year.

Furthermore, IRYCIS is accredited with the European Commission's seal of excellence for its Human Resources Strategy for Researchers (HRS4R), which involves evaluating their activities, promoting equity, pursuing efficiency and quality, and recognizing achievements. Likewise, we are enhancing both our internal and external visibility and promoting initiatives for equality.

As someone visiting our website, I invite you to delve deeper into our 6 reorganized and relaunched research areas, our groups, projects, and initiatives. We aim to bring the science developed by IRYCIS closer to the public and to be an active agent in our society's development. To achieve this, we are constantly updating and improving our content. We envision IRYCIS as an excellent research institute that is accessible and participatory, with the patient at the core of our work and a mission to impact society. Whether you are a patient or a citizen, we encourage you to send us suggestions and reach out for further information. You too can, if you wish, become part of the IRYCIS Community.

And in the age of "circular concepts," this presentation of our website should conclude just as it began, with recognition and gratitude. As the Scientific Director, I want to express my deep appreciation and pay tribute to the outstanding professionals who make up IRYCIS. THANK YOU to all the individuals who, day after day, build and enhance our Institute. Without your talent, professionalism, dedication, commitment, and humanity, IRYCIS wouldn't be the excellent scientific reality that we all recognize today, capable of providing solutions to patients and society. Let's keep up the great work, team!

Mission

To provide a space dedicated to excellent biomedical research, aimed at generating useful knowledge for the identification and treatment of current or potential diseases. We will therefore have a marked translational character in the permanent search for impact on society, with a vocation to become a national and international reference and apply a philosophy of quality and continuous improvement to all our daily activities.

Vision

Lead the basic, clinical and translational research, becoming a benchmark of trust for society, for the scientific community and for public and private institutions at the national and international level.

Contribute significantly to the generation of new knowledge, its application to the healthcare practice and business environment and the training of new researchers in biomedicine.

Identify, through the search for its singularities, a hallmark of scientific identity that allows IRYCIS to contribute added value to the national and international panorama of scientific and biomedical research institutions of excellence.

Work in collaboration with society in the permanent search for the social impact of the Institute's R&D&I.

Values

• Search for excellence
• Leadership
• Innovation and focus on the transfer of results 
• Internationalization
• The orientation of health and society challenges  
• Basic-clinical and multidisciplinary collaboration
• Technical training
• Effective management
• Comprehensive quality
• Professional recognition
• Dissemination of research activities

Accreditations

• Accreditation granted on March 14, 2011, by the Minister of Science and Innovation
• First reaccreditation granted on January 9, 2017, by the Minister of Economy, Industry, and Competitiveness
• Second reaccreditation granted on January 9, 2022, by the Minister of Science and Innovation

Strategic Plan ATENEA 2021-2025

The strategic formulation for the 2021-2025 period at IRYCIS is summarized as follows:

STRATEGIC FORMULATION OF THE ATENEA 21-25 PLAN
1ST CORE. ORGANIZATIONAL STRUCTURE	Axis 1. HUMAN RESOURCES
	Vertical strategic lines
	Talent retention Identification of emerging or new talent Talent acquisition
	Cross-cutting strategic lines
	HRS4R action plan Generational replacement plan Gender, equality, and balance program for leadership positions
	Axis 2. INFRAESTRUCTURE AND SPACES
	Update and review of spaces, facilities, and equipment Evaluation, improvement, and expansion of cross-cutting scientific-technical support services Identification of new scientific-technical support services aligned with the Institute's strategic scientific priorities
	Axis 3. ORGANIZATION, QUALITY, AND INTEGRATION
	Promotion of management professionalization and incorporation of new multidisciplinary technical capabilities in line with the variety, complexity, and global support needs of the Institute Orientation of IRYCIS towards quality Promotion of member integration within the Institute Strengthening of management and support tools
	Axis 4. KNOWLEDGE PROYECTION AND TRANSLATION
	Internationalization of IRYCIS activities Innovation and knowledge transfer
	Axis 5. IRYCIS BRAND AND SOCIAL IMPACT
	Corporate visibility Social impact
2ND CORE. SCIENTIFIC STRUCTURE	Axis 6. SINGULARITIES
	Development and promotion of IRYCIS's unique themes with societal impact Development of plans to advance thematic singularities
	Axis 7. SCIENTIFIC AREAS
	Reorganization and relaunch of existing areas Creation of new areas Development of action plans for each IRYCIS area
	Axis 8. SCIENTIFIC LEADERSHIP
	Identification and promotion of leaders within IRYCIS